regorafenib,nivolumab
bms,bayer
['solid tumor', ' 1209p', ' 1227p', 'nivo', 'nivolumab', 'regorafenib']
posters to look at #esmo2022: 1209p #regorafenib + #nivolumab in pts with recurrent or metastatic solid tumors: results of the escc cohort 1227p #regorafenib + #nivolumab + #folfox in her2 negative #egc #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB